| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Gross margin | 35,7 k € | +416.8% | -11,3 k € | +1.3% | -11,4 k € | +34.5% | -17,4 k € | |
| EBITDA | 35,7 k € | +413.5% | -11,4 k € | +1.0% | -11,5 k € | +35.3% | -17,8 k € | |
| Operating profit | 28,8 k € | +258.4% | -18,2 k € | +0.6% | -18,3 k € | -3.2% | -17,8 k € | |
| Profit/loss | 23,4 k € | +226.4% | -18,5 k € | +1.5% | -18,8 k € | -6.3% | -17,7 k € | |
| Equity | -21,6 k € | +52.0% | -44,9 k € | -69.9% | -26,4 k € | -245.1% | -7,7 k € | |
| Total assets | 12,5 k € | -38.9% | 20,5 k € | -25.7% | 27,5 k € | -37.1% | 43,8 k € | |
| Cash | 46,4 € | -37.6% | 74,4 € | -63.7% | 205,0 € | -96.9% | 6,6 k € | |
| Debts | 34,1 k € | -47.9% | 65,4 k € | +21.2% | 54,0 k € | +4.9% | 51,5 k € | |
Source: Belgian Official Gazette
Private limited company · Antwerpen · incorporated on 13/04/2022
Private limited company with a balanced profile. Cash position declining (-37.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
RedoxForte Health Care is a Private limited company incorporated in 2022. Its main activity is: Technical testing and analysis. Its registered office is in Antwerpen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.